BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31033952)

  • 1. Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice.
    Su X; Shen Y; Jin Y; Jiang M; Weintraub N; Tang Y
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31033952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosome-Derived Dystrophin from Allograft Myogenic Progenitors Improves Cardiac Function in Duchenne Muscular Dystrophic Mice.
    Su X; Jin Y; Shen Y; Ju C; Cai J; Liu Y; Kim IM; Wang Y; Yu H; Weintraub NL; Jiang M; Tang Y
    J Cardiovasc Transl Res; 2018 Oct; 11(5):412-419. PubMed ID: 30155598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of critical molecular pathways involved in exosome-mediated improvement of cardiac function in a mouse model of muscular dystrophy.
    Su X; Shen Y; Jin Y; Weintraub NL; Tang YL
    Acta Pharmacol Sin; 2021 Apr; 42(4):529-535. PubMed ID: 32601364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.
    Chun JL; O'Brien R; Song MH; Wondrasch BF; Berry SE
    Stem Cells Transl Med; 2013 Jan; 2(1):68-80. PubMed ID: 23283493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy.
    Aminzadeh MA; Rogers RG; Fournier M; Tobin RE; Guan X; Childers MK; Andres AM; Taylor DJ; Ibrahim A; Ding X; Torrente A; Goldhaber JM; Lewis M; Gottlieb RA; Victor RA; Marbán E
    Stem Cell Reports; 2018 Mar; 10(3):942-955. PubMed ID: 29478899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
    Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
    Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-modifying bioactivity of intravenous cardiosphere-derived cells and exosomes in mdx mice.
    Rogers RG; Fournier M; Sanchez L; Ibrahim AG; Aminzadeh MA; Lewis MI; Marbán E
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin Deficiency Causes Progressive Depletion of Cardiovascular Progenitor Cells in the Heart.
    Jelinkova S; Sleiman Y; Fojtík P; Aimond F; Finan A; Hugon G; Scheuermann V; Beckerová D; Cazorla O; Vincenti M; Amedro P; Richard S; Jaros J; Dvorak P; Lacampagne A; Carnac G; Rotrekl V; Meli AC
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nestin expression in end-stage disease in dystrophin-deficient heart: implications for regeneration from endogenous cardiac stem cells.
    Berry SE; Andruszkiewicz P; Chun JL; Hong J
    Stem Cells Transl Med; 2013 Nov; 2(11):848-61. PubMed ID: 24068741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifetroban reduces coronary artery dysfunction in a mouse model of Duchenne muscular dystrophy.
    Mitchell R; Frederick NE; Holzman ER; Agobe F; Allaway HCM; Bagher P
    Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H52-H58. PubMed ID: 34048282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.
    Maruyama R; Yokota T
    Methods Mol Biol; 2021; 2224():203-214. PubMed ID: 33606217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy.
    Domenig SA; Bundschuh N; Lenardič A; Ghosh A; Kim I; Qabrati X; D'Hulst G; Bar-Nur O
    Stem Cell Reports; 2022 Feb; 17(2):321-336. PubMed ID: 34995499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors.
    Matre PR; Mu X; Wu J; Danila D; Hall MA; Kolonin MG; Darabi R; Huard J
    Stem Cells; 2019 Dec; 37(12):1615-1628. PubMed ID: 31574188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation.
    Cui CH; Uyama T; Miyado K; Terai M; Kyo S; Kiyono T; Umezawa A
    Mol Biol Cell; 2007 May; 18(5):1586-94. PubMed ID: 17314403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial Ablation of Non-Myogenic Progenitor Cells as a Therapeutic Approach to Duchenne Muscular Dystrophy.
    Gao Z; Lu A; Daquinag AC; Yu Y; Huard M; Tseng C; Gao X; Huard J; Kolonin MG
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute AT
    Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
    J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular phenotype of the
    Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
    Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy.
    Oliveira-Santos A; Dagda M; Burkin DJ
    Hum Mol Genet; 2022 Jul; 31(14):2358-2369. PubMed ID: 35157045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.